Biotech company PrimeGen US will go public in the United States through a $1.5 billion business combination with blank-check firm DT Cloud Star Acquisition, the companies announced Wednesday. The deal is expected to close in the second half of 2026, after which the combined entity will operate as PrimeGen US and list on the Nasdaq primeGen us to go public via $1.5B SPAC deal with DT Cloud Star Acquisition in 2026.
Biotech company PrimeGen US will go public in the United States through a $1.5 billion business combination with blank-check firm DT Cloud Star Acquisition, the companies announced Wednesday.
The deal is expected to close in the second half of 2026, … [1208 chars]
Source: USA Herald | Published: 2026-02-04T20:57:53Z
Credit: USA Herald
